Search by Drug Name or NDC

    NDC 76326-0001-20 Fludeoxyglucose 300 mCi/mL Details

    Fludeoxyglucose 300 mCi/mL

    Fludeoxyglucose is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by The Regents of the University of Michigan. The primary component is FLUDEOXYGLUCOSE F-18.

    Product Information

    NDC 76326-0001
    Product ID 76326-001_289f1038-12cd-4ca1-91f0-38e1b3563e77
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Fludeoxyglucose
    Proprietary Name Suffix F18
    Non-Proprietary Name Fludeoxyglucose F18
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 300
    Active Ingredient Units mCi/mL
    Substance Name FLUDEOXYGLUCOSE F-18
    Labeler Name The Regents of the University of Michigan
    Pharmaceutical Class Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204531
    Listing Certified Through 2024-12-31

    Package

    NDC 76326-0001-20 (76326000120)

    NDC Package Code 76326-001-20
    Billing NDC 76326000120
    Package 19 mL in 1 VIAL, GLASS (76326-001-20)
    Marketing Start Date 2015-07-17
    NDC Exclude Flag N
    Pricing Information N/A
    << 76318-0643-30 76328-0100-00 >>

    Contents